9:11 am Ultragenyx Pharma announces presentation of data from a single patient treated with recombinant human beta-glucuronidase at 10th Annual World Lysosomal Disease Network Symposium; Preliminary data showed a reduction in lysosomal stor
View todays social media effects on RARE
View the latest stocks trending across Twitter. Click to view dashboard
See who Ultragenyx is hiring next, click here to view
